Krensavage Asset Management, LLC Long-Term Concentrated

CIK: 0001609251 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value ($000): $308,111 (100.0% shares, 0.0% debt)

Holdings (10)

MCK Mckesson Corp 16.3%

Value ($000) $50,167 Shares 373,297 Est. Cost $138.18 Unrealized -14.0%

UTHR United Therapeutics Corp 13.9%

Value ($000) $42,956 Shares 550,299 Est. Cost $126.32 Unrealized -26.0%

BIIB Biogen Inc 13.4%

Value ($000) $41,291 Shares 176,556 Est. Cost $314.89 Unrealized -26.7%

ENTA Enanta Pharmaceuticals Inc 13.1%

Value ($000) $40,467 Shares 479,576 Est. Cost $37.52 Unrealized +139.8%

AMGN Amgen Inc 12.9%

Value ($000) $39,694 Shares 215,402 Est. Cost $143.61 Unrealized +1.8%

GILD Gilead Sciences Inc 12.1%

Value ($000) $37,242 Shares 551,237 Est. Cost $53.09 Unrealized -4.3%

ELAN Elanco Animal Health Inc 9.8%

Value ($000) $30,145 Shares 891,851 Est. Cost $31.75 Unrealized +2.3%

— RTI Surgical HDS Inc 5.4%

Value ($000) $16,650 Shares 3,917,744 Est. Cost $4.39 Unrealized —

— Invacare Corp 2.2%

Value ($000) $6,910 Shares 1,331,409 Est. Cost $12.03 Unrealized —

AVNS Avanos Medical Inc 0.8%

Value ($000) $2,589 Shares 59,378 Est. Cost $64.35 Unrealized -33.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MCK	Mckesson Corp	373,297	$50,167	16.3%	$138.18	-14.0%	COM	58155Q103
UTHR	United Therapeutics Corp	550,299	$42,956	13.9%	$126.32	-26.0%	COM	91307C102
BIIB	Biogen Inc	176,556	$41,291	13.4%	$314.89	-26.7%	COM	09062X103
ENTA	Enanta Pharmaceuticals Inc	479,576	$40,467	13.1%	$37.52	+139.8%	COM	29251M106
AMGN	Amgen Inc	215,402	$39,694	12.9%	$143.61	+1.8%	COM	031162100
GILD	Gilead Sciences Inc	551,237	$37,242	12.1%	$53.09	-4.3%	COM	375558103
ELAN	Elanco Animal Health Inc	891,851	$30,145	9.8%	$31.75	+2.3%	COM	28414H103
—	RTI Surgical HDS Inc	3,917,744	$16,650	5.4%	$4.39	—	COM	74975N105
—	Invacare Corp	1,331,409	$6,910	2.2%	$12.03	—	COM	461203101
AVNS	Avanos Medical Inc	59,378	$2,589	0.8%	$64.35	-33.5%	COM	05350V106